Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Income from Continuing Operations (2016 - 2025)

Macrogenics (MGNX) has disclosed Income from Continuing Operations for 14 consecutive years, with 14155000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 8.21% to 14155000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 76299000.0 through Dec 2025, down 9.53% year-over-year, with the annual reading at 74620000.0 for FY2025, 11.43% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 14155000.0 at Macrogenics, down from 16822000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 56309000.0 in Q3 2024, with the low at 66638000.0 in Q1 2022.
  • Average Income from Continuing Operations over 5 years is 31992250.0, with a median of 41043500.0 recorded in 2021.
  • The sharpest move saw Income from Continuing Operations plummeted 2583.69% in 2021, then soared 258.61% in 2024.
  • Over 5 years, Income from Continuing Operations stood at 58236000.0 in 2021, then surged by 120.58% to 11983000.0 in 2022, then crashed by 511.87% to 49354000.0 in 2023, then skyrocketed by 68.75% to 15421000.0 in 2024, then grew by 8.21% to 14155000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 14155000.0, 16822000.0, and 36251000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.